Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Hong Kong Centre for Cerebro-Cardiovascular Health Engineering Limited has 2 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 2 examiners and 2 art units, indicating separate examination paths.
MOSHER, ERIC PARKER is the listed busiest examiner, with 1 pending matter. Counsel should maintain matter-specific response plans while coordinating positions across the two assignments.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (33%) |
| §112 only | 1 (33%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MOSHER, ERIC PARKER | 1 | 75.0% | +75.0% |
| GERIDO, DWAN A | 1 | 58.1% | +30.4% |
| WESTERBERG, NISSA M | 1 | 23.4% | +37.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17536193 | Composition and A Method For Diagnosing And Treating Bacterial Infection | WESTERBERG, NISSA M | 37d overdue |
| 17876787 | Method Of Diagnosing Cardiovascular Diseases, And A Device For Separating Components Of A Fluid Sample For Diagnosing Cardiovascular Diseases | GERIDO, DWAN A | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17536193 | Composition and A Method For Diagnosing And Treating Bacterial Infection | WESTERBERG, NISSA M | 37d overdue |
| 18519493 | MANGANESE-BASED ORGANIC FRAMEWORK AND PREPARATION METHOD AND DRUG DELIVERY METHOD | MOSHER, ERIC PARKER | 21d |
| 17876787 | Method Of Diagnosing Cardiovascular Diseases, And A Device For Separating Components Of A Fluid Sample For Diagnosing Cardiovascular Diseases | GERIDO, DWAN A | — |
| Art Unit | Apps |
|---|---|
| 1612 | 1 |
| 1797 | 1 |
| 1618 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18519493 | MANGANESE-BASED ORGANIC FRAMEWORK AND PREPARATION METHOD AND DRUG DELIVERY METHOD | MOSHER, ERIC PARKER | 1612 | §112 | Final Rejection | 21d | Pending | Nov 27, 2023 |
| 17876787 | Method Of Diagnosing Cardiovascular Diseases, And A Device For Separating Components Of A Fluid Sample For Diagnosing Cardiovascular Diseases | GERIDO, DWAN A | 1797 | §101 | Non-Final OA | — | Pending | Jul 29, 2022 |
| 17536193 | Composition and A Method For Diagnosing And Treating Bacterial Infection | WESTERBERG, NISSA M | 1618 | §103§112 | Non-Final OA | 37d overdue | Pending | Nov 29, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialHong Kong Centre for Cerebro-Cardiovascular Health Engineering Limited has 3 pending office actions as of November 2026, spread across 3 art units and 3 examiners.
Eric Parker Mosher has the most, with 1 of Hong Kong Centre for Cerebro-Cardiovascular Health Engineering Limited's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.